×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Company: PD TREM2 Targeting Companies
company
825 words
KG: PD
2026-03-31
section:companies
kind:company
state:published
topic:parkinsons-disease
topic:trem2
topic:neuroinflammation
topic:microglia
Contents
PD TREM2 Targeting Companies
Knowledge Graph
Related Hypotheses (10)
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
APOE-TREM2 Interaction Modulation
Score: 0.48
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
TREM2-Dependent Microglial Senescence Transition
Score: 0.74
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Phase-Separated Organelle Targeting
Score: 0.52
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.36
Show 5 more
Related Analyses (20)
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
Does SYK activation provide neuroprotection or exacerbate ne
neurodegeneration · failed
What are the optimal timing windows for TREM2 agonism vs ant
neurodegeneration · failed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Show 15 more
Related Experiments (4)
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
See Also (7)
TREM2 Gene
gene · Pages share 4 hypotheses
al002-trem2-agonist-alzheimers
clinical_trial · Pages share 4 hypotheses
sTREM2 (Soluble TREM2) - Biomarker
biomarker · Pages share 4 hypotheses
sTREM2 (Soluble TREM2) - Microglial Biomarker
biomarker · Pages share 4 hypotheses
TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk
mechanism · Pages share 3 hypotheses
TREM2 in Frontotemporal Dementia
mechanism · Pages share 3 hypotheses
TREM2 in Amyotrophic Lateral Sclerosis
mechanism · Pages share 3 hypotheses
Show 2 more
Knowledge Graph (12 edges)
PD
causes
NEURODEGENERATION
PD
causes
DOPAMINERGIC_NEURONS
PD
causes
neurodegeneration
PD
contributes_to
synucleinopathies
PD
associated_with
DEPRESSION
PD
associated_with
T2DM
NEUROINFLAMMATION
contributes_to
PD
NEUROTROPHINS
treats
PD
AGE
associated_with
PD
SNCA
causes
PD